Narcotic Drugs (Licence Charges) Regulation 2016

I, General the Honourable Sir Peter Cosgrove AK MC (Ret’d), Governor‑General of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, make the following regulation.

Dated 08 December 2016

Peter Cosgrove

Governor‑General

By His Excellency’s Command

Sussan Ley

Minister for Health and Aged Care

Contents

1 Name

2 Commencement

3 Authority

4 Definitions

5 Imposition of charge—prescribed period

6 Amount of charge

1  Name

  This is the Narcotic Drugs (Licence Charges) Regulation 2016.

2  Commencement

 (1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

 (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

  This instrument is made under the Narcotic Drugs (Licence Charges) Act 2016.

4  Definitions

  In this instrument:

Act means the Narcotic Drugs (Licence Charges) Act 2016.

commercial cannabis research licence has the meaning given by subsection 54A(1) of the Narcotic Drugs Regulation 2016.

medicinal cannabis licence has the same meaning as in the Narcotic Drugs Act 1967.

non‑commercial cannabis research licence has the meaning given by subsection 54A(2) of the Narcotic Drugs Regulation 2016.

5  Imposition of charge—prescribed period

  For the purposes of paragraph 6(1)(b) of the Act, the prescribed period for a licence is the period starting when the licence comes into force and ending when the licence ceases to be in force.

6  Amount of charge

  For the purposes of subsection 8(1) of the Act, the amount of charge for a licence is as follows:

 (a) for a medicinal cannabis licence—$27,360 for each period of 12 months, or part of a period of 12 months, for which the licence is in force;

 (b) for a commercial cannabis research licence—$27,360 for each period of 12 months, or part of a period of 12 months, for which the licence is in force;

 (c) for a non‑commercial cannabis research licence—$27,360 for the period for which the licence is in force.